Free Trial

Enveric Biosciences (ENVB) Insider Trading & Ownership

Enveric Biosciences logo
$0.32 0.00 (-1.04%)
(As of 12/20/2024 05:45 PM ET)

Enveric Biosciences (NASDAQ:ENVB) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.20%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$2,140.00
Number Of
Insiders Selling
(Last 3 Years)
0
Get ENVB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Enveric Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ENVB Insider Buying and Selling by Quarter

Enveric Biosciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/15/2023Frank PasqualoneDirectorBuy1,000$2.14$2,140.00  
(Data available from 1/1/2013 forward)

ENVB Insider Trading Activity - Frequently Asked Questions

The list of insiders at Enveric Biosciences includes Frank Pasqualone. Learn more on insiders at ENVB.

1.20% of Enveric Biosciences stock is owned by insiders. Learn more on ENVB's insider holdings.

The following insider purchased ENVB shares in the last 24 months: Frank Pasqualone ($2,140.00).

Insiders have purchased a total of 1,000 ENVB shares in the last 24 months for a total of $2,140.00 bought.

Enveric Biosciences Key Executives

  • Dr. Joseph Edward Tucker Ph.D. (Age 55)
    CEO & Director
    Compensation: $450.79k
  • Mr. Kevin M. Coveney CPA (Age 60)
    Chief Financial Officer
    Compensation: $385.62k
  • Dr. Peter J. Facchini Ph.D. (Age 60)
    Chief Innovation Officer
    Compensation: $233.27k


This page (NASDAQ:ENVB) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners